|
|
|
|
|
|
| |
|
Newsletter Sponsor
|
|
Different Name. Same Customer Focus
Thomas H. Lee Partners, L.P. (“THL”) and Frazier Healthcare Partners (“Frazier”) announced they have acquired Adare Pharmaceuticals, which will be rebranded Adare Pharma Solutions (“Adare”), a leading specialty contract development and manufacturing organization (CDMO) and global provider of advanced pharmaceutical technologies, from TPG Capital. The acquisition includes Adare’s CDMO, pharmaceutical technology and microbiome businesses, while TPG Capital will retain rights to Adare’s Eosinophilic Esophagitis (EoE) product, which has been spun out into a separate entity.
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Featured Whitepaper |
 |
|
| |
Steritest NEO Sterility Testing Devices
Our Steritest™ NEO devices simplify every aspect of testing, from handling to traceability, all within a closed concept system. The ease and convenience of this closed assembly enable you to increase productivity while maintaining the highest levels of quality and reliability. When used with the Steritest™ Symbio pump and Steritest™ culture media and fluids, the Steritest™ system delivers unmatched sterility testing consistency. Since 1974, we have been the market leader in sterility testing. ...
read more »
|
|
eBook: TOC and Microbial Detection Monitoring
Proper and thorough monitoring of pharmaceutical water systems is imperative to deliver the highest quality products to patients. read more »
|
|
 |
| |
|
| |
|
Events |
|
|
| |
|
|
|
|
Ophthalmic Drugs Conference
Kensington, London – 11/23/2020
SMi proudly presents the 4th Annual Ophthalmic Drugs Conference taking place on the 23rd-24th of November 2020, in London.
The global ophthalmic ...
event details » |
 |
|
|
 |
|
|
